Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
GV1001 for Alzheimer's Disease
Recruiting0 awardsPhase 2
Miami, Florida
This trialis testing a drug (GV1001) to treat mild to moderate Alzheimer's disease by reducing the amount of proteins that damage the brain. In a completed study, the drug showed promising results and was safe.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service